This finding is contextualized by our prior research, which identified an upstream oncogenic driver of this pathway: PIK3CA mutations in breast cancer cells activate the PI3K/5-LOX/LTB4 axis to promote the recruitment and accumulation of MDSCs in the tumor microenvironment [14]. Here, ALOX5 is linked to breast carcinoma.